In the latest news, Musk's brain-computer interface company Neuralink successfully conducted its first human clinical trial, implanting a brain-computer interface device and announcing that the patient has recovered well. This marks a significant advancement for Neuralink in human clinical research since receiving FDA approval last year. The experiment is a step towards Neuralink's exploration of commercialization and represents a milestone in the company's commitment to developing brain-computer interface technology. The company's ultimate goal is to create a full-brain interface, bringing biology and artificial intelligence closer together.